Praga Manuel, Morales Enrique
Nephrology Division, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.
Nephron. 2017;136(4):273-276. doi: 10.1159/000447674. Epub 2016 Jul 15.
Obesity-related glomerulopathy (ORG) is characterized by glomerulomegaly accompanied in many patients by lesions of focal and segmental glomerulosclerosis. Slowly increasing subnephrotic proteinuria is the commonest presentation of ORG. Occasionally, massive proteinuria (>5-10 g/day) is detected, but the typical findings of nephrotic syndrome are characteristically absent even in patients with massive proteinuria. Superimposed obesity can fuel the progression of other renal diseases, and a reduced number of functioning nephrons (of congenital or acquired causes) synergizes with obesity to induce end-stage renal disease. Weight loss, either induced by diet or bariatric surgery, and renin-angiotensin blockers are effective treatments to slow progression, but a significant proportion of cases will develop end-stage renal disease.
肥胖相关肾小球病(ORG)的特征是肾小球肿大,许多患者伴有局灶节段性肾小球硬化病变。亚肾病范围蛋白尿缓慢增加是ORG最常见的表现。偶尔会检测到大量蛋白尿(>5-10克/天),但即使是大量蛋白尿患者也通常没有肾病综合征的典型表现。叠加的肥胖会加速其他肾脏疾病的进展,而功能肾单位数量减少(先天性或后天性原因)与肥胖协同作用可导致终末期肾病。通过饮食或减肥手术诱导的体重减轻以及肾素-血管紧张素阻滞剂是减缓疾病进展的有效治疗方法,但很大一部分病例仍会发展为终末期肾病。